Press Releases 2015
Boston Scientific receives CE mark for next generation WATCHMAN FLX™ left atrial appendage closure device
Nov 19, 215
First Implants Occur in Europe, Commencing Limited Market Release.
Results from the prospective, multi-centre EWOLUTION registry presented at AHA conference - Nov 9, 2015
Topline data confirming peri-procedural safety of left atrial appendage (LAA) occlusion with the WATCHMAN™ Left Atrial Appendage (LAA) Closure device ...
Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device - Mar 13, 2015
Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN Left Atrial Appendage Closure Device.